Yeming Wang to Multicenter Studies as Topic
This is a "connection" page, showing publications Yeming Wang has written about Multicenter Studies as Topic.
Connection Strength
0.123
-
Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial. Trials. 2020 May 24; 21(1):422.
Score: 0.123